Matrix Medical
Use of a Genomic-based Prognostic Tool to Inform Clinical Decisions for Patients with Cutaneous Melanoma

Shannon Trotter, DO
Oakview Dermatology

Joseph Michael Guenther, MD
St. Elizabeth Physicians


Clinical Decisions in Melanoma

Shannon Trotter, DO

  • Melanoma epidemiological update
  • Genomics
  • NCCN Guidelines
  • Surgical treatment
Clinical Validity Evidence for 31-GEP

J. Michael Guenther, MD

  • SLNB guidance
  • Management and risk recurrence
  • Prospective studies
Panel Discussion with Q&A and Conclusions

For best results, use Chrome, Firefox or Safari browsers

Click here to take the post-test after the presentation.

CME Certificate Fulfillment
An email notification will be issued directly to your inbox with a direct link to the post-activity CME evaluation form at the immediate conclusion of each webinar that you attend. CME certificates will be emailed upon successful completion of the evaluation form, and verification of attendance.

Target Audience
This activity has been developed to meet the educational needs of dermatologists, nurse practitioners, physician assistants, and staff who are dedicated to the management of patients with cutaneous melanoma.

Activity Goal
This activity is designed to address the following core and team competencies:
Patient Care, Medical Knowledge, Practice-based learning and improvement, Interprofessional Collaboration, and Roles & Responsibilities.

Accreditation Statement
Jointly Accredited Provider, Interprofessional Continuing Education
This activity has been planned and implemented by Cinè-Med and Matrix Medical Communications. Cinè-Med is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians: Cinè-Med designates this live activity for a maximum of 1.25 AMA PRA Category 1Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Cinè-Med provides 1.25 Contact Hour for Nurses.

Disclosure Policy
Matrix Medical Communications and Cinè-Med adheres to accreditation requirements regarding industry support of continuing medical education. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.

All Matrix Medical Communications and Cinè-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of Matrix Medical Communications and Cinè-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

Matrix Medical Communications and Cinè-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Non-Endorsement Statement
Matrix Medical Communications and Cinè-Med verifies that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. Matrix Medical Communications and Cinè-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

Educational support provided by:
This activity is supported by educational grants from Castle Biosciences.